Abrilada Kit
Product Images NDC 50090-8032

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Abrilada (NDC 50090-8032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Abrilada 01)

A line graph comparing the percent of ACR20 responders over time (in weeks) between a 40 mg every other week treatment group and a placebo group. The graph shows higher response rates for the 40 mg group throughout the 48-week period.*

FDA Label Image

Figure 2 (Abrilada 02)

A line graph depicting the percentage of ASAS 20 response over 26 weeks comparing Adalimumab (N=208) and placebo (N=107). The x-axis represents time in weeks, and the y-axis shows the percentage response, illustrating higher and sustained response rates for Adalimumab compared to placebo.*

FDA Label Image

Study Uv I (Abrilada 02a)

A line graph depicting treatment failure rate (%) over time in months for two groups: placebo and adalimumab. The graph shows treatment failure rate on the vertical axis and time from 0 to 20 months on the horizontal axis. The placebo group demonstrates a higher failure rate compared to the adalimumab group over the observation period, with data points and numbers of patients at risk indicated below the x-axis for both groups.*

FDA Label Image

Study Uv Ii (Abrilada 02b)

A line graph showing treatment failure rate percentage over time in months. The graph compares three groups labeled as Treatment, Placebo, and Adalimumab, depicting their failure rates from 0 to 20 months. Data points are annotated with sample sizes below the x-axis at various time intervals.*

FDA Label Image

Pfizer (Abrilada 03)

FDA Label Image

Pfizer (Abrilada 04)

FDA Label Image

Step 3 (Abrilada 05)

Step 3 illustration showing how to check the medicine and expiration date on a device, focusing on a close-up of the inspection area with a finger pointing to the medicine cartridge or label. The image is part of instructions likely related to the use of a kit for ABRILADA (adalimumab-afzb).*

FDA Label Image

Image (Abrilada 06)

An instructional diagram of the ABRILADA kit showing the injection device components, including the cap, window, injection button, and the location of the expiration date label near the injection button. The device is white with a purple tip on the button and includes a visible label window.*

FDA Label Image

Step 4 (Abrilada 07)

An instructional illustration showing the injection site options for ABRILADA adalimumab-afzb kit. It depicts a human torso highlighting recommended areas to prepare for injection: the abdomen (at least 2 inches or 5 cm away from the belly button) and the front upper thigh.*

FDA Label Image

Step 5 (Abrilada 08)

An instructional illustration showing Step 5 in using the ABRILADA kit, demonstrating the removal of the cap from the medication device by pulling it off with fingers.*

FDA Label Image

C:\temp\pfizer Oct 4\attached File _1664891496641_2578536_2022_09_20_81a33cfa-262f_11027\abrilada-09.jpg (Abrilada 09)

Instructional illustration showing Step 6 for using the ABRILADA kit. It depicts a hand holding the device with an arrow indicating the needle should be inserted and pushed down into the skin. Close-up insets highlight needle insertion and pushing down action.*

FDA Label Image

Step 7 (Abrilada 10)

An instructional diagram illustrating Step 7 for injecting a medicine using a prefilled device. It shows a hand pressing the injection button until a first click, then holding the device with the needle inserted while waiting for a second click, and finally holding for 5 more seconds to complete the injection.*

FDA Label Image

Step 8 (Abrilada 11)

Instructional illustration showing Step 8 in a sequence, advising to check the window of a medical device or syringe held by a hand. The highlighted window area appears red, indicating where to look during the process, likely part of an instructional guide for using ABRILADA kit components.*

FDA Label Image

Step 9 (Abrilada 12)

Illustration showing Step 9 of a process involving a pen-type device for the drug ABRILADA (adalimumab-afzb). The image depicts a hand gripping the device and removing the pen cap or cover, indicated by a red upward arrow, as part of device preparation or use instructions.*

FDA Label Image

Step 10 (Abrilada 13)

An instructional illustration showing Step 10 in the disposal process for a pen device. The image depicts a hand holding a used pen above a sharps disposal container, indicating the action of safely disposing of the used pen cap or device in the container.*

FDA Label Image

Step 11 (Abrilada 14)

An instructional illustration showing a hand holding a cotton ball or swab, pressing it gently on an injection site after administration. The top left corner includes a bubble with the text 'Step 11' and the caption 'After your Injection.' This image is part of a sequence guiding post-injection care for the ABRILADA adalimumab-afzb kit.*

FDA Label Image

Image (Abrilada 15)

Illustration showing two methods of subcutaneous injection site preparation for the ABRILADA kit: the stretch method involving pulling the skin horizontally, and the pinch method involving pinching the skin vertically, with red arrows indicating the directions of skin movement.*

FDA Label Image

Pfizer (Abrilada 16)

FDA Label Image

Image (Abrilada 17)

An instructional diagram of a syringe kit showing labeled parts: plunger rod, barrel, window displaying the expiration date, and needle cover. The expiration date is highlighted with a magnified view indicating the format as YYYY MMM DD.*

FDA Label Image

Step 3 (Abrilada 18)

Instructional illustration showing step 3 for using the ABRILADA kit: a hand is peeling back the packaging to unpack the prefilled syringe, indicated by a red upward arrow above the syringe.*

FDA Label Image

Step 4 (Abrilada 19)

An instructional illustration showing a hand holding a medication vial or pen, with the step caption 'Step 4 Check your medicine and expiration date' indicating a step in proper medication preparation or administration.*

FDA Label Image

Step 5 (Abrilada 20)

Instructional illustration showing preparation of injection sites for self-administration. Highlights abdomen area, specifying to keep at least 2 inches (5 cm) away from the belly button, and front upper thigh areas on both legs as recommended injection sites.*

FDA Label Image

Step 6 (Abrilada 21)

Illustration showing Step 6 in medication preparation: a person holding a syringe and removing the needle cover by pulling it straight upward. An upward red arrow indicates the direction to remove the needle cover.*

FDA Label Image

Step 7 (Abrilada 22)

An instructional diagram showing the step to insert a needle at a 45-degree angle into the skin during injection. The illustration depicts a hand holding a syringe and another hand positioned to receive the injection, with a 45-degree angle indicated.*

FDA Label Image

Step 8 (Abrilada 23)

An instructional illustration labeled Step 8 showing a hand injecting medicine with a syringe into the skin. A red arrow indicates the proper injection technique, depicting a close-up view of the syringe bevel entering the skin.*

FDA Label Image

Step 9 (Abrilada 24)

An instructional illustration showing a hand holding a syringe with the text 'Step 9 Check your syringe'. The image highlights verification of the syringe before use, as part of a multi-step procedure likely from the ABRILADA (adalimumab-afzb) kit directions.*

FDA Label Image

Step 10 (Abrilada 25)

An instructional illustration labeled Step 10, showing a hand disposing of a used syringe into a designated sharps container. The syringe is being released into the opening of the container as part of a safe disposal process.*

FDA Label Image

Step 11 (Abrilada 26)

Illustration labeled Step 11 showing a hand holding or pressing down on a cotton ball or pad, indicating a step to be taken after a previous action, likely related to medication administration or preparation.*

FDA Label Image

Pfizer (Abrilada 27)

FDA Label Image

Label Image (Lbl500908032)

ABRILADA (adalimumab-afzb) kit packaging label from A-S Medication Solutions. The label states the product contains adalimumab-afzb, with each kit including 40 mg/0.8 mL prefilled syringes. The package includes two single-dose prefilled syringes with 29 gauge x 0.5 inch size needles, and a 2 mg dose syringe. The label also lists the product NDC as 50090-8032-0 and shows directions for use and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.